Corteva (NYSE:CTVA – Get Free Report) updated its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share guidance of 3.600-3.800 for the period, compared to the consensus estimate of 3.740. The company issued revenue guidance of -, compared to the consensus revenue estimate of $18.3 billion.
Analysts Set New Price Targets
CTVA has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft upped their price target on shares of Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. Bank of America boosted their target price on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research note on Monday, July 20th. Jefferies Financial Group upped their target price on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Mizuho lifted their price target on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a report on Tuesday, July 14th. Finally, BNP Paribas Exane boosted their price objective on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $90.19.
Read Our Latest Stock Report on CTVA
Corteva Price Performance
Corteva (NYSE:CTVA – Get Free Report) last announced its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. The firm had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts forecast that Corteva will post 3.76 EPS for the current year.
Corteva Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.8%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.
Institutional Trading of Corteva
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Brighton Jones LLC increased its holdings in shares of Corteva by 307.2% in the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after buying an additional 11,760 shares in the last quarter. Woodline Partners LP grew its holdings in shares of Corteva by 40.3% in the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after acquiring an additional 16,644 shares during the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Corteva by 62.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after purchasing an additional 980 shares during the last quarter. Cresset Asset Management LLC boosted its position in shares of Corteva by 2.6% in the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock valued at $526,000 after purchasing an additional 181 shares during the period. Finally, Jump Financial LLC purchased a new position in Corteva in the 2nd quarter worth about $1,464,000. 81.54% of the stock is currently owned by institutional investors.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
See Also
- Five stocks we like better than Corteva
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
